Written especially for nurses caring for patients with cancer, the
2017 Oncology Nursing Drug Handbook uniquely expresses drug therapy
in terms of the nursing process: nursing diagnoses, etiologies of
toxicities, and key points for nursing assessment, intervention,
and evaluation. Updated annually, this essential reference provides
valuable information on effective symptom management, patient
education, and chemotherapy administration. Completely revised and
updated, the 2017 Oncology Nursing Drug Handbook includes separate
chapters on molecular and immunologic/biologic targeted therapies.
These chapters provide fundamental reviews to assist nurses in
understanding the cellular communication pathways disrupted by
cancer. It also offers simplified content, attention to
understanding the immune checkpoint inhibitors, new information
about immunotherapy, new drugs and their indications, and updated
indications and side effects for recently FDA approved drugs. New
drugs include: alectinib (Alecensa), atezolizumab (Tecentriq),
cabozantinib tablets (Cabometyx), cabozantinib capsules (Cometriq),
cobimetinib tablets (Cotellic), colistin/polymixin B, clotrimazole,
daratumumab (Darzalex), elotuzumab (Empliciti), irinotecan liposome
injection (Onivyde), ixazomib (Ninlaro), melphalan for injection
(Evoela), necitumumab (Portrazza), osimertinib (Targrisso),
pentamidine, posaconazole, peramivir, rolapitant (Varubi) ,
talimogene laherparepvec (Imlygic), Tamiflu, trabectedin
(Yondelis), uridine triacetate (Vistogard granules), venetoclax
(Venclexta), vincristine liposome injection (Marqibo), and
zanamivir.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
